The highest mortality from nervous system diseases is observed in the United States, significantly surpassing other countries. Japan and Brazil follow but with considerably lower figures. Countries like Iceland and Luxembourg have the least recorded male deaths. The United States shows a notable year-on-year increase in mortality with a 6.3% rise in 2023, while Slovenia shows the highest growth rate at 9.01%. In contrast, South Africa and Israel have decreasing trends. The 2023 figures indicate stability for Spain and Hungary.
Looking ahead, the increasing trend in the U.S. and Slovenia suggests a need for more targeted health interventions and awareness programs in those regions. Conversely, it is essential to continue monitoring the ongoing decrease or stability in other countries to better understand contributing factors for these changes.
Top countries in Nervous System Disease Mortality by Country
| # | 10 Countries | Units (Male Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 123,250 | 2023 | +5.28% | +6.3% | View data |
| 2 | 2 Japan | 27,530 | 2023 | +4.74% | +4.26% | View data |
| 3 | 3 Brazil | 23,880 | 2023 | +4.27% | +5.1% | View data |
| 4 | 4 United Kingdom | 22,580 | 2023 | +4.8% | +5.41% | View data |
| 5 | 5 Germany | 19,820 | 2023 | +3.17% | +2.43% | View data |
| 6 | 6 Spain | 10,320 | 2023 | -0.18% | -0.0058% | View data |
| 7 | 7 Mexico | 7,560 | 2023 | +1.94% | +2.23% | View data |
| 8 | 8 Canada | 7,480 | 2023 | +2.01% | +2.04% | View data |
| 9 | 9 South Korea | 6,100 | 2023 | +3.8% | +3.49% | View data |
| 10 | 10 Australia | 5,560 | 2023 | +3.94% | +5.02% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...